In immune-mediated inflammatory diseases, the overall risk for serious adverse events is not notably higher with combo ...

An international team of clinical collaborators, led by physician scientists from Dana-Farber Cancer Institute, performed a ...

In an effort to find new treatments for castrate-resistant prostate cancer, a TTUHSC research team led by Srinivas Nandana, ...

Targeted therapies have significantly improved outcomes for patients with non-small cell lung cancer (NSCLC) with actionable mutations. However, many tumors inevitably develop drug resistance and ...

During a live event, Benjamin Garmezy, MD, discussed treatment options in renal cell carcinoma including IO/TKI combinations ...

Nowadays, more people are opting for micro-therapy, a shorter therapy form, instead of longer sessions. Here’s why.

A team of Singapore scientists has made a significant discovery in understanding stomach cancer, a disease that remains one ...

Pulmonary hypertension is a common consequence of interstitial lung disease (PH-ILD), with the highest rate seen among ...

An expert discusses how medical professionals have integrated tagraxofusp into blastic plasmacytoid dendritic cell neoplasm ...

Crystal Aguh, MD, FAAD, Johns Hopkins School of Medicine faculty, highlights the critical need for comprehensive education on hair loss across diverse hair types, stressing the importance of ...

Character Biosciences has raised $93m in an oversubscribed Series B funding round to expedite the progression of precision ...

IIT-G and Bose Institute develop advanced injectable hydrogel for precise cancer treatment, minimizing side effects on ...